Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Genomics Guided Targeted Post-neoadjuvant Therapy in breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: German Cancer Research Center | Conditions: Early-stage Breast Cancer | Phase 2 | Status: RECRUITING